Rapid Dose Therapeutics Corp. RDTCF
0.06 USD -0.02 (-21.10%)
At closeNov 9, 2026, 4:00 PM EST
0.0725 Day range 0.0725
0.0132 52-week range 0.15
- YTD
- -36.44%
- 1 year
- -61.87%
- Market cap
- 7.88M
- EPS (ttm)
- -0.03
- YTD return
- -36.44%
- 1-year return
- -61.87%
- Volume
- 7.00K
- Avg volume
- 4.83K
- Open
- 0.0725
- Previous close
- 0.0725
- Day's range
- 0.0725 – 0.0725
- 52-week range
- 0.0132 – 0.15
No chart data for this range yet.
News
Rapid Dose Announces Proposed Debt Settlement
Rapid Dose Announces Payment in Shares for Quarterly Interest on Secured Debt and Proposed Issuance of Shares as Payment of Accrued Director Fees
Rapid Dose Therapeutics and Aavishkar Granted Monolayer QuickStrip(TM) Nicotine Patent, Advancing RDT's Global Commercialization Strategy
Rapid Dose Therapeutics (DOSE) (RDTCF) and Bodhi Health Expand Distribution and Sales of CurcuWIN(R) QuickStrip(TM) Curcumin Across Canada
Rapid Dose Therapeutics Extends Strategic Collaboration with Global Nicotine Leader and Initiating Saudi Arabia Commercialization
Rapid Dose Therapeutics (DOSE) (RDTCF) Advances Pharmaceutical Manufacturing Expansion with Burlington Facility Upgrades Targeting Global Medical Markets
Rapid Dose Announces Payment in Shares for Quarterly Interest on Secured Debt
Rapid Dose Therapeutics (DOSE) (RDTCF) Secures Patent for QuickStrip(TM) Nicotine Oral Film Targeting $38B Smoke-Free Nicotine Market
Rapid Dose Therapeutics Advances Cannabinoid Research and Clinical Evaluation of QuickStrip(TM) Platform
Rapid Dose Therapeutics Begins Trading on the OTCQB in the United States Under Symbol RDTCF, Expanding Access for U.S. Healthcare and Biotechnology Investors
Your note
Sign in to keep a note on RDTCF — it syncs with the Stock Master app.
